Funding Opportunity PA-18-192 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to encourage applications that use human laboratory paradigms and/or clinical trials to evaluate the safety and efficacy of novel or re-purposed compounds, that bind to new targets, for treatment of alcohol use disorder (AUD) or AUD with a comorbid post-traumatic stress disorder.

Funding Opportunity PA-18-096 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to indicate a continued interest in the topic area of vulvodynia or chronic vulvar pain of unknown etiology as an integral area of branch research.This announcement is intended to encourage new research applications in the exploration of etiology, prevention, diagnosis, and therapeutics in the field of vulvodynia. Applications utilizing multidisciplinary approaches and interdisciplinary investigative teams are of particular interest to advance this research agenda.

Funding Opportunity PA-18-089 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to indicate a continued interest in the topic area of vulvodynia or chronic vulvar pain of unknown etiology as an integral area of branch research.This announcement is intended to encourage new research applications in the exploration of etiology, prevention, diagnosis, and therapeutics in the field of vulvodynia. Applications utilizing multidisciplinary approaches and interdisciplinary investigative teams are of particular interest to advance this research agenda.

Funding Opportunity PA-18-054 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of diverse population groups and thereby improve the effectiveness of health interventions and services for individuals within those groups. Priority is placed on understudied populations distinctive health risk profiles. This funding opportunity announcement (FOA) focuses on sexual and gender minority (SGM) populations, including lesbian, gay, bisexual, transgender, and intersex populations. Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.

Funding Opportunity PA-18-040 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of diverse population groups and thereby improve the effectiveness of health interventions and services for individuals within those groups. Priority is placed on understudied populations with distinctive health risk profiles. This funding opportunity announcement (FOA) focuses on sexual and gender minority (SGM) populations, including lesbian, gay, bisexual, transgender, and intersex populations. Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.

Funding Opportunity PA-18-037 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) is committed to supporting research that will increase scientific understanding of the health status of diverse population groups and thereby improve the effectiveness of health interventions and services for individuals within those groups. Priority is placed on understudied populations with distinctive health risk profiles. This funding opportunity announcement (FOA) focuses on sexual and gender minority (SGM) populations, including lesbian, gay, bisexual, transgender, and intersex populations. Basic, social, behavioral, clinical, and services research relevant to the missions of the sponsoring Institutes and Centers may be proposed.

Funding Opportunity PAR-18-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for basic and translational research on caregiving for individuals with Alzheimers disease (AD), at the individual, family, community, and population level. The scope of this funding opportunity includes support for applications that propose the following: interventions to reduce caregiver burden and improve patient outcomes across various settings; population- and community-based research on the scope and impact of AD caregiving; improved characterization of informal and formal caregiving and the burden of caregiving across the full spectrum of the disease, including differences amongsocioeconomic, racial/ethnic and geographic sub-populations; and research addressing the unique challenges related to the provision of advanced AD care, including disparities in access to care.

Funding Opportunity PAR-18-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided planning and/or execution therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools. As many such preliminary evaluations are early in development, this FOA will provide investigators with support for pilot (Phase I and II) cancer imaging clinical trials, including patient monitoring and laboratory studies. This FOA supports novel uses of known/standard clinical imaging agents and methods as well as the evaluation of new agents, systems, or methods. The imaging and image-guided intervention (IGI) investigations, if proven successful in these early clinical trials, can then be validated in larger studies through competitive R01 mechanisms, or through clinical trials in the Specialized Programs of Research Excellence (SPOREs), Cancer Centers and/or the NCI's National Clinical Trials Network.

Funding Opportunity RFA-AG-18-021 from the NIH Guide for Grants and Contracts. The National Institute on Aging is seeking applications on systems biology approaches using non-mammalian laboratory animal models to increase our understanding of the basic biology underpinning neurodegeneration. It is expected that research supported under this FOA will provide new insights into molecular networks that might be involved in causing, amplifying or protecting against neurodegeneration, and that, in turn, might ultimately contribute to Alzheimer's disease or related dementias. Importantly, a major goal of this FOA is to use interaction and regulatory networks produced and analyzed using systems biology to gain these new insights. Because this FOA is directed toward discovery, currently employed genetically modified laboratory animals used to study AD are not required, although they may be used. Because this FOA requires systems biology approaches, data used to build interaction or regulatory networks may also come from humans or other mammals in which AD, related dementias, or aging-related cognitive decline have been observed. This FOA will only support studies using non-mammalian laboratory animal models; studies involving humans or experiments with mammals will not be allowed under this FOA.

This includes but is not limited to, Sanger sequencing, next generation sequencing, whole genome sequencing, PCR and other amplification methods, real-time PCR,...
From Merieux NutriSciences - Sun, 05 Nov 2017 11:47:47 GMT - View all Crete, IL jobs

This position includes access to extensive molecular research capabilities at PNNL, including world\-class multi\-omics measurement capability, strong...
From Pacific Northwest National Laboratory - Sat, 04 Nov 2017 08:28:44 GMT - View all Richland, WA jobs

Work closely with experimental researchers to generate/provide analysis reports, project reports and perform requested custom analysis etc....
From ACGT, Inc. - Sat, 04 Nov 2017 06:46:15 GMT - View all United States jobs

Experience in bioinformatics. This position requires a strong understanding of bioinformatics principals, as the stakeholders they will be interacting with are...
From George Washington University - Sat, 04 Nov 2017 01:57:52 GMT - View all Foggy Bottom, MD jobs

Education should be in the fields of Molecular Biology, Biochemistry, Computational Biology, Bioinformatics or related disciplines....
From Bristol-Myers Squibb - Fri, 03 Nov 2017 17:06:17 GMT - View all Hopewell, NJ jobs

Notice NOT-OD-18-011 from the NIH Guide for Grants and Contracts

Notice NOT-HL-17-557 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-154 from the NIH Guide for Grants and Contracts. The National Institute of Nursing Research (NINR) seeks to promote the development of HIV interventions which target opportunities to improve the delivery of healthcare across the continuum of care for persons infected with HIV.

Funding Opportunity PA-18-153 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age, and prevent illness and disability in later years.

Funding Opportunity PA-18-136 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to promote the development of HIV interventions which target opportunities to improve the delivery of healthcare across the continuum of care for persons infected with HIV.

Funding Opportunity PA-18-134 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age, and prevent illness and disability in later years.